Skip to main content
Log in

Performance of diagnostic criteria in pediatric Behçet’s disease

  • Observational Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Behçet's disease is an inflammatory vasculitic disease of unknown etiology characterized by recurrent oral and genital ulcers, ocular findings, and multiple organ involvement. Mucocutaneous findings are the most common symptoms. The most used diagnostic criteria are International Criteria for BD (ICBD), International Study Group (ISG) criteria and pediatric Behçet’s disease criteria (PEDBD). Although diagnostic criteria have been defined, the diagnosis is still difficult due to clinical findings developed in pediatric patients. The aim of this study was to evaluate the clinical findings, phenotype characteristics, sensitivity and specificity of diagnostic criteria, and the course of pediatric Behçet's disease (BD). We evaluated retrospectively the files of 67 (29 M/38 F) patients diagnosed with BD according to expert opinion. The patients were reclassified according to ISG, ICBD, and PEDBD criteria. The control group consisted of a total of 69 patients with BD-mimicking diseases or presenting at least one major BD sign followed at the same center. Sensitivity and specificity were evaluated for the criteria. The mean age of diagnosis was 13.38 ± 3.2 years. There were oral aphthous ulcers in 98.5%, genital ulcers in 68.7%, skin lesions in 31.3%, vascular involvement in 17.9%, neurological involvement in 11.9%, positive pathergy test in 33.8%, and positive HLA-B51 in 57.1% of patients. The sensitivity of ICBD, ISG and PEDBD criteria was 88.1, 43.3, and 37.3%, respectively. The specificity of ICBD, ISG, and PEDBD criteria was 100%. Diagnosis of BD in childhood is still difficult. ICBD criteria have the highest sensitivity among the diagnostic criteria. These criteria can also be used in childhood.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V (2019) One year in review 2019: Behçet’s syndrome. Clin Exp Rheumatol 37(Suppl 121):3–17

    PubMed  Google Scholar 

  2. Shahram F, Nadji A, Akhlaghi M, Faezi ST, Chams-Davatchi C, Shams H et al (2018) Pediatric Behçet’s disease in Iran: report of 204 cases. Clin Exp Rheumatol 36(6 Suppl 115):135–140

    PubMed  Google Scholar 

  3. Ishido T, Horita N, Takeuchi M, Kawagoe T, Shibuya E, Yamane T et al (2017) Clinical manifestations of Behçet’s disease depending on sex and age: results from Japanese nationwide registration. Rheumatology (Oxford) 56(11):1918–1927

    Article  Google Scholar 

  4. Karincaoglu Y, Borlu M, Toker SC, Akman A, Onder M, Gunastı S et al (2008) Demographic and clinical properties of juvenile-onset Behçet’s disease: a controlled multicenter study. J Am Acad Dermatol 58(4):579–584

    Article  Google Scholar 

  5. Rodríguez-Carballeira M, Solans R, Larrañaga JR, García-Hernández FJ, Rios-Fernández R, Nieto J et al (2018) Venous thrombosis, and relapses in patients with Behçet’s disease. Descriptive analysis from Spanish network of Behçet’s disease (REGEB cohort). Clin Exp Rheumatol. 36(6 Suppl):40–44

    PubMed  Google Scholar 

  6. Maldini C et al (2018) Exploring the variability in Behcet’s disease prevalence: a metaanalytical approach. Rheumatology (Oxford) 57(1):185–195

    Article  Google Scholar 

  7. Poddighe D, Turganbekova A, Mukusheva Z, Abdirakhmanova A, Assylbekova M, Abdrakhmanova S (2020) HLA-B*51 allelic and carrier frequency in Kazakhstan: insights into Behçet’s disease prevalence in Central Asia. Intern Emerg Med. https://doi.org/10.1007/s11739-020-02369-1

    Article  PubMed  Google Scholar 

  8. Akkoç N (2018) Update on the epidemiology, risk factors and disease outcomes of Behçet’s disease. Best Pract Res Clin Rheumatol 32(2):261–270

    Article  Google Scholar 

  9. Davatchi F, Sadeghi Abdollahi B, Chams-Davatchi C, Shahram F, Shams H, Nadji A et al (2015) The saga of diagnostic/classification criteria in Behcet’s disease. Int J Rheum Dis 18(6):594–605

    Article  Google Scholar 

  10. Criteria for diagnosis of Behçet’s disease (1990) International Study Group for Behçet’s disease. Lancet 335(8697):1078–1080

    Google Scholar 

  11. International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD) (2014) The International Criteria for Behçet’s Disease ICBD: a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28(3):338–347

    Article  Google Scholar 

  12. Kone-Paut I et al (2016) Consensus classification criteria for pediatric Behcet’s disease from a prospective observational cohort: PEDBD. Ann Rheum Dis 75(6):958–964

    Article  Google Scholar 

  13. Krause I, Uziel Y, Guedj D et al (1999) Childhood Behcet’s disease: clinical features and comparison with adult-onset disease. Rheumatology 38(5):457–462

    Article  CAS  Google Scholar 

  14. Batu ED, Sönmez HE, Sözeri B, Butbul Aviel Y, Bilginer Y, Özen S (2017) The performance of different classification criteria in pediatric Behcet’s disease. Clin Exp Rheumatol 35(Suppl 108):119–123

    PubMed  Google Scholar 

  15. Gallizzi R et al (2017) A national cohort study on pediatric Behcet’s disease: cross sectional data from an Italian registry. Pediatr Rheumatol Online J 15(1):84

    Article  Google Scholar 

  16. Maldini C, Lavalley MP, Cheminant M, de Menthon M, Mahr A (2012) Relationships of HLA-B51 or B5 genotype with Behcet’s disease clinical characteristics: systematic review and meta-analyses of observational studies. Rheumatology (Oxford) 51(5):887–900

    Article  Google Scholar 

  17. Ambrose NL, Haskard DO (2013) Differential diagnosis and management of Behçet syndrome. Nat Rev Rheumatol 9(2):79–89

    Article  CAS  Google Scholar 

  18. Kang EH, Kim JY, Takeuchi F, Kim JW, Shin K, Lee EY et al (2011) Associations between the HLA-A polymorphism and the clinical manifestations of Behcet’s disease. Arthritis Res Ther 13(2):R49

    Article  CAS  Google Scholar 

Download references

Funding

The research did not receive funding.

Author information

Authors and Affiliations

Authors

Contributions

TK, MD Organization of the paper and substantial contribution to the acquisition of data. FA, NT, MS, ZET, EC, CK, SC, BA, MD Organization of the paper and revision critically for intellectual content.

Corresponding author

Correspondence to Tuba Kurt.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Ethical approval

Ethics committee approval was received for this study, from the scientific and ethics committee of our hospital (approval number: E1/891/20202; approval date: February 7, 2020).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kurt, T., Aydın, F., Sezer, M. et al. Performance of diagnostic criteria in pediatric Behçet’s disease. Rheumatol Int 42, 127–132 (2022). https://doi.org/10.1007/s00296-020-04777-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-020-04777-0

Keywords

Navigation